Product Description: BMY-21502 (BMS-181168) is a pyrrolidinone derivative with memory- and cognition-enhancing activities. BMS-181168 attenuates hypoxia-induced deterioration in brain function, as delta/theta decreases, alpha activity increases and the centroid of the combined delta/theta waves is accelerated[1].
Applications: Neuroscience-Neuromodulation
Formula: C15H19F3N4O
References: [1]Saletu B, et al. BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies. Pharmacopsychiatry. 1994 Sep;27(5):189-97./[2]Saletu B, et al. BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies. Pharmacopsychiatry. 1994 Sep;27(5):189-97.
CAS Number: 123259-91-6
Molecular Weight: 328.33
Research Area: Neurological Disease
Target: Drug Derivative
Deutsch
English
